|
|
ViaCell Acquires Cerebrotec to Form Neuroscience Division.
- Article from:
-
PR Newswire
- Article date:
-
July 25, 2001
|
Copyright informationCOPYRIGHT 2001 PR Newswire Association, Inc. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Noted Neuroscientist, Dr. Seth Finklestein, to Head New
Division Focusing on Cellular and Molecular Medicines for
The Treatment of Stroke and Other Neurological Diseases
BOSTON, July 25 /PRNewswire/ --
ViaCell, Inc., a premier cellular pharmaceuticals company, today announced it has acquired Boston-based Cerebrotec, a neuroscience company focused on the development of novel therapeutic products for stroke recovery.
The ViaCell Neuroscience Division will be formed as a result of this acquisition and will combine Cerebrotec's research in the use of stem cells and neurotrophic growth factors for treatment of stroke with ViaCell's patented Selective ...